Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 6 , Pages 753-759 , December 2010

Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax

  • Soheila Kheradmandnia, MSc

      Affiliations

    • Department of Chemical Engineering, Tarbiat Modares University, Tehran, Iran
    • ,
  • Ebrahim Vasheghani-Farahani, PhD

      Affiliations

    • Department of Chemical Engineering, Tarbiat Modares University, Tehran, Iran
    • Corresponding Author InformationCorresponding author: Department of Chemical Engineering, Tarbiat Modares University, P.O. Box 14115-143, Tehran, Iran.
    • ,
  • Mohsen Nosrati, PhD

      Affiliations

    • Department of Chemical Engineering, Tarbiat Modares University, Tehran, Iran
    • ,
  • Fatemeh Atyabi, PhD

      Affiliations

    • Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Received 3 January 2010 ,Accepted 12 June 2010.

References 

  1. Hou D, Xie C, Huang K, Zhu C. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials. 2003;24:1781–1785
  2. Li Y, Dong L, Jia A, Chang X, Xue H. Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine. Int J Biol Macromol. 2006;38:296–299
  3. Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161–177
  4. Müller RH, Keck CM. Challenges and solutions for the delivery of biotech drugs—a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol. 2004;113:151–170
  5. Mühlen AZ, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery—drug release and release mechanism. Eur J Pharm Biopharm. 1997;45:149–155
  6. Mehnert W, Mäder K. Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165–196
  7. Lim SJ, Kim CK. Formulation parameters determining the physiochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm. 2002;243:135–146
  8. Kim BD, Na K, Choi HK. Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan. Eur J Pharm Sci. 2005;24:199–205
  9. In:  Hodgson BB,  Kizior RJ,  Kingdon R editor. Nurse's drug handbook. Philadelphia: W.B. Saunders Company; 1993;p. 557–558
  10. In:  Doyle RM editors. Nursing 2008 drug handbook. 28th ed. Philadelphia: Wolters Kluwer Health; 2008;p. 382–383
  11. Üner M, Gönüllü Ü, Yener G, Altmkurt T. A new approach for preparing controlled release ketoprofen tablets by using beeswax. Il Farmaco. 2004;60:27–31
  12. Meastrelli F, González-Rodríguez ML, Rabasco AM, Mura P. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery. Int J Pharm. 2006;312:53–60
  13. Arida AI, Al-Tabakha MM. Encapsulation of ketoprofen for controlled drug release. Eur J Pharm Biopharm. 2007;66:48–54
  14. Manna L, Banchero M, Sola D, Ferri A, Ronchetti S, Sicardi S. Impregnation of PVP microparticles with ketoprofen in the presence of supercritical CO2. J Supercrit Fluids. 2006;42:378–384
  15. Vergote GJ, Vervate C, Van Driessche I, Hoste S, De Smedt S, Demeester J, et al. An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. Int J Pharm. 2001;219:81–87
  16. Vergote GJ, Vervate C, Van Driessche I, Hoste S, De Smedt S, Demeester J, et al. In vivo evaluation of matrix pellets containing nanocrystalline ketoprofen. Int J Pharm. 2002;240:79–84
  17. Paolino D, Ventura CA, Nistico S, Puglisi G, Fresta M. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int J Pharm. 2002;244:21–31
  18. Valenta C, Wanka M, Heidlas J. Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug. J Control Release. 1999;63:165–173
  19. Chattopadhyay P, Shekunov BY, Yim D, Cipolla D, Boyd B, Farr S. Production of solid lipid nanoparticle suspensions (SFEE) for pulmonary delivery using AERx system. Adv Drug Deliv Rev. 2007;59:444–453
  20. Ugazio E, Cavalli R, Gasco MR. Incorporation of cyclosporin A in solid lipid nanoparticles (SLN). Int J Pharm. 2002;241:341–344
  21. Liu J, Gong T, Wang C, Zhong Z, Zhang ZR. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine based mixed micelles: preparation and characterization. Int J Pharm. 2007;340:153–162
  22. Westesen K, Siekmann B, Koch MHJ. Investigation on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction. Int J Pharm. 1993;93:189–199
  23. Schubert MA, Muller-Goymann CC. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm. 2005;61:77–86
  24. Myers D. In: Surfactant science and technology. 3rd ed.. Hoboken: NJ: Wiley; 2006;p. 380
  25. Attama AA, Müller-Goymann CC. Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity. Colloids Surf A. 2008;315:189–195
  26. Attama AA, Müller-Goymann CC. Characterization of solid lipid nanoparticles with mixed lipid core for controlled drug delivery applications. Eur J Pharm Biopharm. 2007;67:48–57
  27. Cavalli R, Peiraa E, Caputo O, Gasco MR. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with B-cyclodextrins. Int J Pharm. 1999;182:59–69
  28. Lv Q, Yu A, Xi Y, Li H, Song Z, Cui J, et al. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm. 2009;372:191–198
  29. Ölbrich C, Müller RH. Enzymatic degradiation of SLN—effect of surfactant and surfactant mixtures. Int J Pharm. 1999;180:31–39
  30. Hurrell S, Cameron RE. The effect of buffer concentration, pH and buffer ions on the degradation and drug release from polyglycolide. Polym Int. 2003;52:358–366
  31. Özyazıcı M, Gökçe EH, Ertan G. Release and diffusional modeling of metronidazole lipid matrices. Eur J Pharm Biopharm. 2006;63:331–339

 This study was supported by a grant from the Iran Nanotechnology Initiative Council. The authors acknowledge support from Laboratory of New Pharmaceutical Systems (Tehran University of Medical Sciences, Faculty of Pharmacy) and Laboratory of Biotechnology (College of Engineering, Tarbiat Modares University).

PII: S1549-9634(10)00164-4

doi: 10.1016/j.nano.2010.06.003

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 6 , Pages 753-759 , December 2010

Article Tools

* Image Usage & Resolution